Coty
COTY INC.
Key figures
Period Jul 2025 to Jun 2026ConsolidatedU.S. GAAP
RevenueDisclosed
US$5.8B
Operating marginCalculated
-1.4%
Net assets to total assetsCalculated
29.3%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★☆☆☆☆position among all companies
-1.4%
Growth (revenue, 4-year average)
★★☆☆☆position among all companies
2.3%
Capital efficiency
★☆☆☆☆position among all companies
-20.2%
Revenue and profit
Performance, financial position and capital allocation
Coty
Recent performance trends
Coty
Cash flow trends
Consolidated indicators (9 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$5.3 billion | US$5.6 billion | US$6.1 billion | US$5.9 billion | US$5.8 billion |
| Operating income | US$0.2 billion | US$0.5 billion | US$0.5 billion | US$0.2 billion | US$-81.50 million |
| Net income | US$0.3 billion | US$0.5 billion | US$89.40 million | US$-0.4 billion | US$-0.6 billion |
| Total assets | US$12.1 billion | US$12.7 billion | US$12.1 billion | US$11.9 billion | US$10.2 billion |
| Shareholders' equity | US$3.2 billion | US$3.8 billion | US$3.8 billion | US$3.5 billion | US$3.0 billion |
| Net cash provided by (used in) operating activities | US$0.7 billion | US$0.6 billion | US$0.6 billion | US$0.5 billion | US$0.5 billion |
| Net cash provided by (used in) investing activities | US$0.3 billion | US$-0.1 billion | US$-0.2 billion | US$-0.1 billion | US$0.5 billion |
| Net cash provided by (used in) financing activities | US$-1.0 billion | US$-0.5 billion | US$-0.3 billion | US$-0.4 billion | US$-1.2 billion |
| Cash and cash equivalents | US$0.2 billion | US$0.2 billion | US$0.3 billion | US$0.3 billion | US$0.2 billion |
Revenue scale in the same industry
Coty
Chemicals and pharmaceuticals: 56 companies · revenue · largest first・each company’s latest fiscal year・Consolidated・Disclosed
- 1 Johnson & JohnsonFY Dec 2025 US$94.2B
- 2 Procter & GambleFY Jun 2026 US$87.0B
- 3 ELI Lilly ANDFY Dec 2025 US$65.2B
- … 32 companies
- 36 Church & Dwight COFY Dec 2025 US$6.2B
- 37 The ChemoursFY Dec 2025 US$5.8B
- 38 CotyThis companyFY Jun 2026 US$5.8B
- 39 HuntsmanFY Dec 2025 US$5.7B
- 40 Sealed AIRFY Dec 2025 US$5.4B
- … 16 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$0.2 billion | Consolidated | Disclosed |
| Cash and cash equivalents | US$0.2 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-1.2 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$0.5 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$0.5 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$0.5 billion | Consolidated | Disclosed |
| Stockholders' equity (including non-controlling interests) | US$3.2 billion | Consolidated | Disclosed |
| Non-controlling interests | US$0.2 billion | Consolidated | Disclosed |
| Net assets | US$3.0 billion | Consolidated | Disclosed |
| Net sales | US$5.8 billion | Consolidated | Disclosed |
| Operating income | US$-81.50 million | Consolidated | Disclosed |
| Net income | US$-0.6 billion | Consolidated | Disclosed |
| Total assets | US$10.2 billion | Consolidated | Disclosed |
| Operating margin | -1.4% | Consolidated | Calculated |
| Net assets to total assets | 29.3% | Consolidated | Calculated |
| Net margin | -10.4% | Consolidated | Calculated |
| Return on equity | -20.2% | Consolidated | Calculated |